Pfizer Discontinues Hemophilia Gene Therapy Beqvez
Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia B product Beqvez.
gene therapy, childhood blindness
Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...
A revolutionary gene therapy treatment in London has improved the vision of children suffering from a rare genetic disorder, ...
IFLScience on MSN17h
Inhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical TrialsA new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 ...
HHS Secretary Robert F. Kennedy Jr. is preparing to remove committee members who advise the government on vaccine approvals ...
Researchers have identified a gene therapy that could prevent life-threatening arrhythmias by restoring the heart’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback